MedPath

YONSA

YONSA (abiraterone acetate) tablets

Approved
Approval ID

ec93b41f-88c2-e7ab-e053-2a95a90a636d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 16, 2023

Manufacturers
FDA

Catalent Pharma Solutions, LLC

DUNS: 825745131

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

abiraterone acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code11014-0566
Product Classification
G
Generic Name
abiraterone acetate
Product Specifications
Route of AdministrationORAL
Effective DateNovember 16, 2023
FDA Product Classification

INGREDIENTS (1)

ABIRATERONE ACETATEActive
Quantity: 125 mg in 1 1
Code: EM5OCB9YJ6
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

YONSA - FDA Drug Approval Details